Claims
- 1. A process for the preparation of a 2-thio penem derivative of formula (IV) or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof: ##STR56## wherein R.sup.1 and R.sup.2 are independently hydrogen; substituted or unsubstituted: C.sub.1-10 alkyl, alkenyl and alkynyl having from 2-10 carbon atoms; cycloalkyl, cycloalkylalkyl, and alkylcycloalkyl, having 3-6 carbon atoms in the cycloalkyl ring and 1-6 carbon atoms in the alkyl moieties thereof; phenyl; aralkyl, aralkenyl, and aralkynyl wherein the aryl moiety is phenyl and the linear chain has 1-6 carbon atoms; wherein the substituent or substituents relative to the above named radicals are selected from the group consisting of: amino, alkanoylamino, mono- and di-alkylamino, hydroxyl, alkoxyl, alkanoyloxy, mercapto, alkylthio, phenylthio, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano and carboxy, and wherein the alkyl moieties of the above-recited substituents have 1-6 carbon atoms; a free hydroxy or mercapto group; an amino or acylamino group of formula (d), (e), (f) or (g): ##STR57## wherein n is 0, 1 or 2; m is 0, 1 or 2; A.sub.7 is an alkyl group of 1-6 carbon atoms, a cycloalkyl group of 3-6 carbon atoms, cyclohexenyl, cyclohexadienyl, phenyl, hydroxyphenyl, thienyl or pyridyl group; x is a hydrogen, bromine or chlorine atom, a carboxylic acid, carboxylate ester, hydroxy, acetoxy, amino, ureido, guanidino or acetylureido group; A.sub.8 is a phenyl, 2,5-dimethoxyphenyl, 2-alkoxy-1-naphthyl, isothiazolyl, 3-phenyl-5-methyl-4-isoxazolyl, 3-o-chlorophenyl-5-methyl-4-isoxazolyl, 3-o,o-dichlorophenyl-5-methyl-4-isoxazolyl, 3-o,o-fluorochlorophenyl-5-methyl-4-isoxazolyl, 3-phenyl-4-isoxazolyl, 3-o-chlorophenyl-4-isoxazolyl, 3-o,o-dichlorophenyl-4-isoxazolyl, 3-o,o-fluorochlorophenyl-4-isoxazolyl group wherein the aryl moiety is phenyl unsubstituted or substituted by up to two halo atoms; X.sub.1 is a CH.sub.2 OCH.sub.2, CH.sub.2 SCH.sub.2 or (CH.sub.2).sub.n group; and X.sub.2 is an oxygen or sulphur atom; or together R.sup.1 and R.sup.2 represent a group .dbd.CR.sup.5 R.sup.6 wherein R.sup.5 and R.sup.6 are the same or different and each represents hydrogen or a C.sub.1-10 hydrocarbon group; and R.sup.3 represents an organic radical having up to 18 carbon atoms selected from a saturated or unsaturated aliphatic, cycloaliphatic, cycloaliphaticaliphatic, phenyl or aralkyl, wherein the aryl moiety is phenyl and the alkyl part has 1-6 carbon atoms, or a heterocyclyl or heterocyclyl-alkyl radical having up to 10 carbon atoms and up to 4 ring hetero atoms selected from the group nitrogen, oxygen and/or sulphur, any of which R.sup.3 groups may be optionally substituted by amino, mono-, di- and tri-(C.sub.1-6) alkylamino, C.sub.1-6 alkanoylamino, hydroxyl, C.sub.1-6 alkylthio, phenylthio, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano, carboxyl, C.sub.1-6 alkoxycarbonyl, and C.sub.1-6 alkanoyloxy which process comprises reacting a sulphoxide of formula (V): ##STR58## wherein R.sup.1 and R.sup.2 are as defined with respect to formula (IV) above, R.sup.x represents hydrogen or a salt, ester or anhydride of the carboxylic acid group which may be readily cleaved under conventional conditions, and R.sup.4 is an organic radical as defined in relation to R.sup.3 in formula (IV) provided that R.sup.4 is different to R.sup.3 ; with a thiol of formula (VI) or a reactive salt thereof:
- R.sup.3 --SH (VI)
- and thereafter if necessary carrying out one or more of the following steps:
- (i) removal of any carboxyl-blocking group R.sup.x ;
- (ii) converting the product to a pharmaceutically acceptable salt or in vivo hydrolysable ester group.
- 2. A process as claimed in claim 1 wherein R.sup.3 is C.sub.1-6 alkyl, C.sub.2-6 alkenyl, aryl, aralkyl wherein the alkyl has 1.varies.6 carbon atoms, heterocyclyl or heterocyclylalkyl, wherein the alkyl has 1-3 carbon atoms, and the heterocyclyl ring comprises 4-6 atoms, up to 4 of which may be selected from oxygen and nitrogen; any group R.sup.3 being optionally substituted.
- 3. A process as claimed in claim 2 wherein the optional substituent is amino, mono-, di-, and tri-(C.sub.1-6) alkylamino, C.sub.1-6 alkanoylamino, hydroxyl, C.sub.1-6 alkoxyl, mercapto, C.sub.1-6 alkylthio, arylthio, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano, carboxyl, C.sub.1-6 alkoxycarbonyl and C.sub.1-6 alkanoyloxy.
- 4. A process as claimed in claim 2 wherein R.sup.3 is optionally substituted C.sub.2-6 alkenyl, aryl or heterocyclyl.
- 5. A process as claimed in claim 1 wherein one of the groups R.sup.1 and R.sup.2 is hydrogen.
- 6. A process as claimed in claim 1 wherein one of the groups R.sup.1 and R.sup.2 is C.sub.1-6 alkyl, optionally substituted with hydroxy or alkanoyloxy.
- 7. A process as claimed in claim 1 wherein R.sup.1 and R.sup.2 together represent a group .dbd.CR.sup.5 R.sup.6 wherein R.sup.5 and R.sup.6 are independently hydrogen, C.sub.1-6 alkyl or phenyl.
Priority Claims (2)
Number |
Date |
Country |
Kind |
8026733 |
Aug 1980 |
GBX |
|
81301683 |
Apr 1981 |
EPX |
|
Parent Case Info
This is a continuation of Ser. No. 291,389, filed Aug. 10, 1981, now abandoned.
US Referenced Citations (3)
Number |
Name |
Date |
Kind |
4347183 |
Afonso et al. |
Aug 1982 |
|
4372965 |
Christensen et al. |
Feb 1983 |
|
4474793 |
Ross et al. |
Oct 1984 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
291389 |
Aug 1981 |
|